Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study
Clinical trial NCT07206511 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07206511
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-10-09
- Primary completion
- 2028-06-30
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.